2026-07-31T08:09:25-04:00 2025-12-31 MILLER COOPER & CO LTD 3 Parkway North Blvd Suite 200 Deerfield IL 60015 990EZ 2025-01-01 883109275 Provenance Precision Medicine Foundation % DAWN BROOKE PROV 7732553611 2410 Harrison Street Evanston IL 60201 Dawn Brooke Executive Director 7732553611 2026-07-15 true P00253365 8472055000 2025 2025-03-06 01:10:19Z X https://provenanceprecisionmedicine.org X X 75510 X 75510 0 0 0 0 0 0 75510 147416 0 12789 262 47103 207570 -132060 202473 70413 X 203976 80038 0 0 0 0 203976 80038 1503 9625 202473 70413 THE PROVENANCE PRECISION MEDICINE FOUNDATION IS COMMITTED TO ADVANCING ACCESS TO INNOVATIVE CANCER TREATMENTS-PARTICULARLY PERSONALIZED CANCER VACCINES AND OTHER IMMUNOTHERAPIES-FOR PATIENTS WITH ADVANCED DISEASE. THROUGH DIRECT PATIENT SUPPORT, EDUCATION, AND FUNDING OF CLINICAL RESEARCH, THE FOUNDATION WORKS TO ACCELERATE THE AVAILABILITY OF THESE THERAPIES IN THE UNITED STATES AND HELP PATIENTS NAVIGATE OPTIONS BEYOND THE STANDARD OF CARE. Provided grants to support individuals with advanced cancer in accessing precision medicine, including genomic testing, personalized treatment recommendations, and innovative therapies such as individualized cancer vaccines. These grants enabled patients to pursue expert-recommended care not typically covered by insurance and supported early decision-making in treatment planning. 147416 147416 Engaged a consultant to initiate research and strategic planning to support access to cancer vaccine clinical trials in the United States. Two board members also traveled to Germany to meet with researchers and clinicians as part of this effort. These activities are part of the Foundation's ongoing work to expand the availability of innovative immunotherapies for patients with advanced cancer. 40813 188229 Dawn Brooke Executive Director/Treasurer 15.0 0 0 0 Saskia Biskup Secretary 1.0 0 0 0 David Parker Chair 3.0 0 0 0 false false false false false false false IL DAWN BROOKE 2410 HARRISON ST Evanston IL 60201 7732553611 false false false false false false false false false false true X 0 30000 11080 120938 75510 237528 0 0 0 30000 11080 120938 75510 237528 141996 95532 0 0 0 237528 X Unusual Grants The organization received the following unusual grants that are excluded from the public support computation under Treasury Regulations section 1.509(a)-3(c)(3) and (4): 2024: 160,527 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Form 990, Part VI, Section C, Line 19 The organization's governing documents, conflict of interest policy, and financial statements are not posted online but are available to the public upon request. Requests may be made via email or in writing to the Foundation's administrative office. Form 990, Part VI, Section B, Line 15a The board did discuss compensation for the Executive Director role. For 2025, the board agreed that executive director would not receive compensation. However, the board did decide that the position would begin receiving compensation starting in 2026. Form 990, Part VI, Section B, Line 12c The organization regularly and consistently monitored and enforced compliance with its conflict-of-interest policy. Potential conflicts were addressed through open discussion during board meetings, and any concerns were documented in the meeting summaries. Board members were expected to proactively disclose any relevant interests, and recusals were made when appropriate. The policy was reaffirmed during our annual board meeting in October 2025. FORM 990EZ PART I LINE 10 DONEES NAME:DCVAX TREATMENT SUPPORT GRANT AMOUNT:147416 FORM 990EZ PART I LINE 16 Description:NEWS LETTERS Amount:695 FORM 990EZ PART I LINE 16 Description:SOFTWARE & APPS Amount:5094 FORM 990EZ PART I LINE 16 Description:BANK FEES Amount:501 FORM 990EZ PART II LINE 26 Description:CHASE CREDIT CARD BOY Amount:1503 EOY Amount:9625